A recent groundbreaking study suggests that thousands of patients utilizing popular weight-loss medications, specifically GLP-1 drugs like Wegovy and Mounjaro, may be experiencing side effects that have largely gone unnoticed in conventional clinical research. This analysis, which delved into over 400,000 online forum posts, has brought to light potential connections between these widely prescribed injections and symptoms such as irregular menstrual periods and various fever-like chills. Researchers indicate that these issues are being spontaneously reported by patients themselves, thereby highlighting a crucial disparity between findings from controlled clinical trials and the real-world experiences of individuals using these drugs.

The innovative research was conducted by scientists from Penn Engineering, who meticulously examined posts on the social media platform Reddit. Their primary objective was to uncover less common adverse effects associated with GLP-1 drugs, which are commonly prescribed for both weight management and diabetes treatment. It is estimated that approximately 1.6 million Britons are currently using these appetite-suppressing medications, with projections indicating a rise to 3.3 million users this year alone. While GLP-1 jabs have already been linked to known adverse reactions, including vision impairment, muscle atrophy, and mental health challenges, clinical trials typically identify only the most prevalent reactions due to their inherent limitations: tracking a restricted number of patients over a defined period.

The Penn Engineering team sought to determine if, now that millions of individuals have been using these medications for several years, patients were expressing other concerns online. Their detailed analysis strongly indicated that changes to menstrual cycles and abrupt fluctuations in body temperature, encompassing chills, hot flushes, and generalized fever-like symptoms, may necessitate more thorough investigation. Sharath Chandra Guntuku, the study's senior author and a professor in Computer and Information Science, commented on the validity of their approach: "Some of the side effects we found, like nausea, are well known, and that shows that the method is picking up a real signal. The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them."

The study revealed that approximately four percent of the Reddit users analyzed reported menstrual irregularities. These issues, which can include missed periods, unusually heavy bleeding, or cycles with significant variations in length, are typically associated with factors like stress, polycystic ovary syndrome, or thyroid disorders. Neil Sehgal, the study's first author and a doctoral student, suggested that this proportion could be "even higher" in research focused exclusively on female participants, asserting, "We think that's a signal worth investigating." The researchers also acknowledged a demographic consideration: Reddit users tend to be predominantly male and primarily based in the United States, which could influence the reported rates of gender-specific side effects.

Overall, about 44 percent of the users whose posts were analyzed reported at least one side effect. Gastrointestinal issues, such as stomach pain and nausea, were the most frequently cited complaints, followed by fatigue as the second most common problem. Beyond these, other users described experiencing chills, feeling unusually cold, sudden hot flushes, and general fever-like symptoms, reinforcing the findings related to body temperature fluctuations.

Jena Shaw Tronieri, a senior research investigator at Penn and a co-author of the study, offered a potential physiological explanation: "These drugs are thought to work by engaging part of the brain called the hypothalamus, which helps regulate a wide variety of hormones." She cautiously added, "That doesn't mean the medications are necessarily causing these symptoms, but it could suggest that reports of menstrual changes and body temperature fluctuations are worth studying more systematically."

Lyle Ungar, a professor in Computer and Information Science and another co-author, emphasized the complementary role of social media data. He noted that while clinical trials are generally effective at identifying the most dangerous side effects of drugs, they can sometimes "fail to find what symptoms patients are most concerned about." Prof Ungar, a long-time researcher in using social media for adverse drug effect identification, likened online patient communities to "a neighbourhood grapevine." He elaborated: "People who are living with these medications are swapping notes with each other in real time, sharing experiences that rarely make it into a doctor's office visit or an official report." Neil Sehgal further underscored that while the researchers could not definitively prove GLP-1 drugs were "actually causing these symptoms," the findings undoubtedly warrant further scrutiny.

In the broader context of drug use, Semaglutide, a prominent GLP-1 drug, became available as a weight-loss treatment in the UK in 2018. Over the past five years, approximately 10.2 million prescriptions have been issued. The majority of users are believed to be accessing these drugs through private channels rather than the NHS, with usage projected to double between 2024 and 2025, further increasing the importance of comprehensive side effect monitoring.